Fight Colorectal Cancer is giving you the opportunity to talk to researchers and medical professionals in April and May through online webinars designed to bring the science of treating colorectal cancer down to the personal.
The latest news from the petri dish
Wednesday, April 20, 2011
8 – 9 PM Eastern
Dr. Yaeger at work in her lab
Dr. Rona Yaeger will discuss the research she has been conducting over the past year with the grant she received as part of Fight Colorectal Cancer’s Lisa Fund research program.
Dr. Yaeger’s research focused on inhibiting the AKT pathway in colorectal cancer cells. She conducted basic research to determine how inhibitors to the pathway might affect cells of patients who have mutated KRAS and are resistant to EGFR inhibiting drugs. Dr. Yaeger has also been conducting a phase II clinical trial with an AKT inhibitor for patients with metastatic colorectal cancer who have normal (wild type) KRAS.
If you are interested in learning more about the future of cancer treatments, or if you’ve ever donated to the Fight Colorectal Cancer Lisa Fund, do not miss this webinar!
Personalizing personalized medicine
Monday, April 25, 2011
8 – 9 PM Eastern
Carolyn Grande, CRNP, AOCNP
Oncology nurse practitioner Carolyn Grande will make personalized medicine a little more personal during this webinar. If you’ve ever heard your doctor mention “tumor markers,” “biomarkers,” “KRAS”, “BRAF,” or “tumor pathways” and wondered what he or she meant, this webinar is for you. In fact, Carolyn may even be able to explain why Rona Yaeger’s pathway research (above) could mean big answers for colorectal cancer patients some day.
Carolyn is a member of Fight Colorectal Cancer’s Medical Advisory Board. In March, she presented this information to the advocates who participated in our Call-on Congress. Her presentation was so popular, we asked and she graciously agreed to make it a part of our webinar program. Don’t miss out!
Treating liver mets
Monday, May 16, 2011
8 – 9 PM Eastern
Dr. Andrew Kennedy
The liver is usually the first place where colorectal cancer metastasizes, so learning to manage tumors in the liver can help stage IV patients survive longer. Fortunately, liver directed therapies have evolved over the last two decades so patients with metastatic or primary liver tumors now have many new treatment options.
We are pleased that one of the leading researchers on liver metastases in the country has agreed to speak about these new options with us and our webinar participants. Join Dr. Andrew Kennedy and learn about how you may be impacted by these new discoveries. Register today.
Don’t worry if you’ve missed some of our webinars.
We archive them! You can watch and listen to the following patient webinars any time (in descending chronological order):
- A Report from the January 2011 GI Cancers Symposium (2/7/2011)
- Does Colorectal Cancer Run in Your Family (12/6/10)
- Stage II Colon Cancer Decision Making (9/20/10)
- Health Care Reform and You (7/13/10)
- Improvements to Care & Screening for Colorectal Cancer (6/21/10)
Help us continue this vital patient program. Make a donation to Fight Colorectal Cancer today.
Leave a Reply
Your comments are welcome. However, specific medical advice will not be provided. Generic QUESTIONS can be directed to our Answer Line team at http://fightcolorectalcancer.org/awareness/answer-line or by calling us at 1-877-427-2111 9:00 AM – 5:00 PM Eastern time, Monday – Friday. We urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. Fight Colorectal Cancer is not responsible for the medical accuracy of any comments left by persons other than Fight Colorectal Cancer staff members. Fight Colorectal Cancer staff members monitor comments and may respond publicly where appropriate.
Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.
We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment.